<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30083054</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>09</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">1178-2234</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>12</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Breast cancer : basic and clinical research</Title>                <ISOAbbreviation>Breast Cancer (Auckl)</ISOAbbreviation>            </Journal>            <ArticleTitle>Kdm4c is Recruited to Mitotic Chromosomes and Is Relevant for Chromosomal Stability, Cell Migration and Invasion of Triple Negative Breast Cancer Cells.</ArticleTitle>            <Pagination>                <MedlinePgn>1178223418773075</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1177/1178223418773075</ELocationID>            <Abstract>                <AbstractText>Members of the jumonji-containing lysine demethylase protein family have been associated with cancer development, although their specific roles in the evolution of tumor cells remain unknown. This work examines the effects of lysine demethylase 4C (KDM4C) knockdown on the behavior of a triple-negative breast cancer cell line. KDM4C expression was knocked-down by siRNA and analyzed by Western blot and immunofluorescence. HCC38 cell proliferation was examined by MTT assay, while breast cancer cells' migration and invasion were tested in Transwell format by chemotaxis. Immunofluorescence assays showed that KDM4C, which is a key protein for modulating histone demethylation and chromosome stability through the distribution of genetic information, is located at the chromosomes during mitosis. Proliferation assays demonstrated that KDM4C is important for cell survival, while Transwell migration and invasion assays indicated that this protein is relevant for cancer progression. These data indicate that KDM4C is relevant for breast cancer progression and highlight its importance as a potential therapeutic target.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Garcia</LastName>                    <ForeName>Jeison</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Doctorate in Biociences, Center of Biomedical Research Universidad de La Sabana-CIBUS, School of Medicine, Universidad de La Sabana, Chía, Colombia.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lizcano</LastName>                    <ForeName>Fernando</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Doctorate in Biociences, Center of Biomedical Research Universidad de La Sabana-CIBUS, School of Medicine, Universidad de La Sabana, Chía, Colombia.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>27</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Breast Cancer (Auckl)</MedlineTA>            <NlmUniqueID>101474356</NlmUniqueID>            <ISSNLinking>1178-2234</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Neoplasia. 2016 Oct;18(10):594-609</RefSource>                <PMID Version="1">27742014</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genome Res. 2014 Jan;24(1):52-63</RefSource>                <PMID Version="1">24285722</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Physiol. 2013 Nov;228(11):2103-8</RefSource>                <PMID Version="1">23589100</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Cancer Drug Targets. 2015;15(4):272-81</RefSource>                <PMID Version="1">25731686</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2009 Jul;100(7):1158-65</RefSource>                <PMID Version="1">19432891</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2010 Dec 14;18(6):590-605</RefSource>                <PMID Version="1">21156283</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2000 Sep 1;60(17):4735-9</RefSource>                <PMID Version="1">10987278</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2003 May;3(5):362-74</RefSource>                <PMID Version="1">12724734</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2009 Dec 17;28(50):4491-500</RefSource>                <PMID Version="1">19784073</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2014 May 30;16(3):R56</RefSource>                <PMID Version="1">24886710</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Genet Cytogenet. 2008 Jan 1;180(1):51-5</RefSource>                <PMID Version="1">18068534</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):18970-5</RefSource>                <PMID Version="1">24191012</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2014 Jun;42(10):6168-82</RefSource>                <PMID Version="1">24728997</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Signal. 2016 Aug;28(8):1124-36</RefSource>                <PMID Version="1">27140681</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int Rev Cell Mol Biol. 2013;303:237-62</RefSource>                <PMID Version="1">23445812</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):E3367-76</RefSource>                <PMID Version="1">23129632</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Opin Pharmacother. 2015 May;16(7):983-98</RefSource>                <PMID Version="1">25881743</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2013 May 15;73(10):2936-42</RefSource>                <PMID Version="1">23644528</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2012 Jan 19;31(3):333-41</RefSource>                <PMID Version="1">21666724</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genet Mol Biol. 2011 Jan;34(1):19-24</RefSource>                <PMID Version="1">21637537</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Biol Cell. 2014 Jan;25(2):302-17</RefSource>                <PMID Version="1">24258023</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2013 Jul 01;13:317</RefSource>                <PMID Version="1">23815808</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmaceuticals (Basel). 2012 Sep 12;5(9):963-90</RefSource>                <PMID Version="1">24280700</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Clin Cancer Res. 2011 Oct 03;30:90</RefSource>                <PMID Version="1">21962223</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Oncol. 2012 Nov;41(5):1701-6</RefSource>                <PMID Version="1">22948256</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Genet Cytogenet. 2006 Jun;167(2):122-30</RefSource>                <PMID Version="1">16737911</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2012 Nov 14;12:516</RefSource>                <PMID Version="1">23148692</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2006 Jul 20;442(7100):307-11</RefSource>                <PMID Version="1">16732293</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2011 Mar 18;6(3):e17830</RefSource>                <PMID Version="1">21445275</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2014 Jul 15;5(13):4779-87</RefSource>                <PMID Version="1">24952432</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2015 Aug;24(4):449-55</RefSource>                <PMID Version="1">25920680</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer (Auckl). 2016 Nov 02;10:169-175</RefSource>                <PMID Version="1">27840577</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Cell Biol. 2007 Mar;9(3):347-53</RefSource>                <PMID Version="1">17277772</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Death Dis. 2014 Aug 14;5:e1379</RefSource>                <PMID Version="1">25118939</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Transl Res. 2014 May 15;6(3):236-47</RefSource>                <PMID Version="1">24936217</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2010 Oct;123(3):725-31</RefSource>                <PMID Version="1">20020197</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Chromosome segregation</Keyword>            <Keyword MajorTopicYN="N">RNA interference</Keyword>            <Keyword MajorTopicYN="N">jumonji domain-containing histone demethylases</Keyword>            <Keyword MajorTopicYN="N">triple-negative breast neoplasms</Keyword>        </KeywordList>        <CoiStatement>Declaration of Conflicting Interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>02</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>04</Month>                <Day>04</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>8</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30083054</ArticleId>            <ArticleId IdType="doi">10.1177/1178223418773075</ArticleId>            <ArticleId IdType="pii">10.1177_1178223418773075</ArticleId>            <ArticleId IdType="pmc">PMC6073829</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>